Journal Logo

Articles by E. Abella

ASSESSMENT OF THE BURDEN OF DISEASE IN TERMS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MULTIPLE MYELOMA NOT ELIGIBLE FOR ASCT IN SPAIN: INTERIM ANALYSIS OF QOLMMBUS STUDY: PS1391

de la Rubia, J.; Domingo, A.; Delgado, O.; More

HemaSphere. 3:638, June 2019.

PERIPHERAL BLOOD INVOLVEMENT BY FLOW CYTOMETRY IS NOT AN UNUSUAL FEATURE IN IGM MGUS/WALDENSTRÖM MACROGLOBULINEMIA WITH MYD88 L265P MUTATION.: PB2009

Montesdeoca, S.; Calvo, X.; Arenillas, L.; More

HemaSphere. 3:908-909, June 2019.

PRESCRIPTION PATTERNS AND OUTCOMES OF FIRST-LINE THERAPY FOR NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA REAL-LIFE PATIENTS ACCORDING TO AGE: A RETROSPECTIVE ANALYSIS OF THE 2012-2016 PERIOD: PB2144

Cejalvo, M. J.; Sureda, A.; González, E.; More

HemaSphere. 3:964-965, June 2019.